Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower genital tract

Genes Chromosomes and Cancer

Volumn 46, Issue 11, 2007, Pages 981-990

  Medeiros, Fabiola ^a   Erickson Johnson, Michele R ^a   Keeney, Gary L ^a   Clayton, Amy C ^a   Nascimento, Antonio G ^a   Wang, Xiaoke ^a   Oliveira, Andre M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG; HIGH MOBILITY GROUP A1A PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BLASTOMA; CHROMOSOME 1P; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FIBROEITHELIAL STROMAL POLYP; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENE FUSION; GENE MAPPING; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; GENITAL TRACT TUMOR; HEMANGIOFIBROMA; HEMANGIOMYXOMA; HUMAN; HUMAN TISSUE; KARYOTYPING; LEIOMYOMA; MAJOR CLINICAL STUDY; MALE; MESENCHYME; MYXOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPINDLE CELL LIPOMA; UPREGULATION;

ADULT; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 12; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENITAL NEOPLASMS, FEMALE; HMGA PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MESODERM; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSLOCATION, GENETIC; UP-REGULATION;

EID: 34848855810     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20483     Document Type: Article

References (31)

1. Arlotta P, Tai AK, Manfioletti G, Clifford C, Jay G, Ono SJ. 2000. Transgenic mice expressing a truncated form of the high mobility
2. group I-C protein develop adiposity and an abnormally high prevalence of lipomas. J Biol Chem 275:14394-14400.
3. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, Chada K. 1995. Disruption of the architechtural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
4. Battista S, Fidanza V, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H, Santoro M, Croce CM, Fusco A. 1999. The expression of a truncated HMGI-C gene induced gigantism associated with lipomatosis. Cancer Res 59:4793-4797.
5. Betz JL, Menoni AM, U'Ren LA, Moore GE, Sandberg AA. 1995. Cytogenetic findings in a case of angiomyxoma of the vaginal wall. Cancer Genet Cytogenet 84:157.
6. Blandamura S, Cruz J, Vergara LF, Puerto IM, Ninfo V. 2003. Aggressive angiomyxoma: A second case of metastasis wit patient's death. Hum Pathol 34:1072-1074.
7. Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, Rippel V, Bullerdiek J, Santoro M, Fusco A. 1998. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17:413-418.
8. Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A. 2001. Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22:1583-1591.
9. Fletcher CD, Tsang WY, Fisher C, Lee KC, Chan JK. 1992. Angiomyofibroblastoma of the vulva: A benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 16:373-382.
10. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, Corson JM. 1991. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 324:436-442.
11. Granter SR, Nucci MR, Fletcher CD. 1997. Aggressive angiomyxoma: Reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases. Histopathology 30:3-10.
12. Hess JL. 1998. Chromosomal translocations in benign tumors: The HMGI proteins. Am J Clin Pathol 109:251-261.
13. Horsman DE, Berean KW, Salski CB, Clement PB. 1991. Aggressive angiomyxoma of the pelvis: Cytogenetic findings in a single case [abstract]. Cancer Genet Cytogenet 56:130-131.
14. ISCN. 2005. An International System for Human Cytogenetic Nomenclature (2005): Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. Shaffer LG, Tommerup N, editors. Basel: Karger.
15. Kazmierczak B, Wanschura S, Meyer-Bolte K, Caselitz J, Meister P, Bartnitzke S, Van de Ven W, Bullerdiek J. 1995. Cytogenic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 147:580-585.
16. Kazmierczak B, Dal Cin P, Wanschura S, Bartnitzke S, Van den Berghe H, Bullerdiek J. 1998. Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors. Am J Pathol 152:431-435.
17. Kazmierczak B, Meyer-Bolte K, Tran KH, Wockel W, Breightman I, Rosigkeit J, Bartnitzke S, Bullerdiek J. 1999. A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer 26:125-133.
18. Kenny-Moynihan MB, Hagen J, Richman B, McIntosh DG, Bridge JA. 1996. Loss of an X chromosome in aggressive angiomyxoma of female soft parts: A case report. Cancer Genet Cytogenet 89:61-64.
19. Kimmel DW, O'Fallon JR, Scheithauer BW, Kelly PJ, Dewald GW, Jenkins RB. 1992. Prognostic value of cytogenetic analysis in human cerebral astrocytomas. Ann Neurol 31:534-542.
20. Ligon AH, Moore SD, Parisi MA, Mealiffe ME, Harris DJ, Ferguson HL, Quade BJ, Morton CC. 2005. Constitutional rearrangement of the architectural factor HMGA2: A novel human phenotype including overgrowth and lipomas. Am J Hum Genet 76: 340-348.
21. Mayer C, Hemann MT, Bartel DP. 2007. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315:1576-1579.
22. Micci F, Panagopoulos I, Bjerkehagen B, Heim S. 2006. Deregulation of HMGA2 in an aggressive angiomyxoma with t(11;12) (q23;q15). Virchows Arch 448:838-842.
23. Nucci MR, Fletcher CD. 2000. Vulvovaginal soft tissue tumours: update and review. Histopathology 36:97-108.
24. Nucci MR, Granter SR, Fletcher CD. 1997. Cellular angiofibroma: A benign neoplasm distinct from angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol 21:636-644.
25. Nucci MR, Weremowicz S, Neskey DM, Sornberger K, Tallini G, Morton CC, Quade BJ. 2001. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Genes Chromosomes Cancer 32:172-176.
26. Quade BJ, Weremowicz S, Neskey DM, Vanni R, Ladd C, Dal Cin P, Morton CC. 2003. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. Cancer Res 63: 1351-1358.
27. Rabban JT, Dal Cin P, Oliva E. 2006. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma. Int J Gynecol Pathol 25:403-407.
28. Reeves R. 2001. Molecular biology of HMGA proteins: Hubs of nuclear function. Gene 277:63-81.
29. Siassi RM, Papadopoulos T, Matzel KE. 1999. Metastasizing aggressive angiomyxoma. N Engl J Med 341:1772.
30. Steeper TA, Rosai J. 1983. Aggressive angiomyxoma of the female pelvis and perineum: Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 7:463-475.
31. Zhou X, Benson KF, Ashar HR, Chada K. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771-774.